✦ LIBER ✦

Heads, Or the Art of Phrenologyby Helen Cooper; Peter Cooper

Book ID: 124536754
Publisher: Stazione Zoologica di Napoli
Year: 1986
Tongue: English
Weight: 160 KB
Volume: 8
Category: Article
ISSN: 0391-9714
DOI: 10.2307/23328885

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and irinotecan in recurrent or

Docetaxel and irinotecan in recurrent or metastatic head and neck cancer : A phase 2 trial of the Eastern Cooperative Oncology Group

✍ Athanassios Argiris; Ashley Buchanan; Bruce Brockstein; Jill Kolesar; Musie Gheb 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

Specification of a patent for an improve

Specification of a patent for an improvement in the art of making glue, by evaporating the water commonly called the foot water, or the liquor after boiling the bones of all kinds of animals, to a proper consistence for cutting, drying, and making into glue, by means of a double floored evaporating basin. Granted to Peter Cooper, City of New York, April 29th, 1880

✍ Peter Cooper 📂 Article 📅 1830 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Prognostic factors and long-term survivo

Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck : An analysis of two Eastern Cooperative Oncology Group randomized trials

✍ Athanassios Argiris; Yi Li; Arlene Forastiere 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

Phase III Study of Radiation Therapy Wit

Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group (E2382)

✍ Harry Quon; Traci Leong; Robert Haselow; Bruce Leipzig; Jay Cooper; Arlene Foras 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 193 KB

A phase 2 trial of bortezomib followed b

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck : A trial of the eastern cooperative oncology group (E1303)

✍ Athanassios Argiris; Musie Ghebremichael; Barbara Burtness; Rita S. Axelrod; Ron 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

## Abstract ## BACKGROUND: Bortezomib, an inhibitor of the 26S proteasome and NF‐κB, may have antitumor activity in adenoid cystic carcinoma (ACC). Preclinical studies have shown synergy between bortezomib and doxorubicin. ## METHODS: Eligibility criteria included incurable ACC, any number of pr

Prospective, randomized comparison of ch

Prospective, randomized comparison of chemotherapy of recurrent or metastatic squamous cancer of the head and neck (SCH&N) with methotrexate (M) versus methotrexate, bleomycin (B) and cis-diamminedichloroplatinum II (D) — an Eastern cooperative oncology group study

✍ Steven E. Vog; David Schoenfeld; Barry H. Kaplan; Harvey Lerner 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 107 KB